These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 29332922)

  • 21. The -509C/T polymorphism of transforming growth factor-beta1 is associated with increased risk for development of chronic idiopathic neutropenia.
    Eliopoulos DG; Mavroudi I; Pontikoglou C; Ximeri M; Stavroulaki E; Pyrovolaki K; Velegraki M; Spanoudakis M; Goulielmos G; Papadaki HA
    Eur J Haematol; 2009 Dec; 83(6):535-40. PubMed ID: 19614955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 5A/6A polymorphism of the stromelysin-1 gene and angiographic restenosis after coronary artery stenting.
    Chiou KR; Chung SL; Charng MJ
    J Chin Med Assoc; 2005 Nov; 68(11):506-12. PubMed ID: 16323393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 677TT polymorphism of methylenetetrahydrofolate reductase in combination with low serum vitamin B12 is associated with coronary in-stent restenosis.
    Chung SL; Chiou KR; Charng MJ
    Catheter Cardiovasc Interv; 2006 Mar; 67(3):349-55. PubMed ID: 16489563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between VEGF Gene Polymorphisms and In-Stent Restenosis after Coronary Intervention Treated with Bare Metal Stent.
    Bagyura Z; Kiss L; Hirschberg K; Berta B; Széplaki G; Lux Á; Szelid Z; Soós P; Merkely B
    Dis Markers; 2017; 2017():9548612. PubMed ID: 28484288
    [No Abstract]   [Full Text] [Related]  

  • 25. Angiotensin-converting enzyme insertion/deletion polymorphism does not influence the restenosis rate after coronary stent implantation.
    Ferrari M; Mudra H; Grip L; Voudris V; Schächinger V; de Jaegere P; Rieber J; Hausmann D; Rothman M; Koschyk DH; Figulla HR;
    Cardiology; 2002; 97(1):29-36. PubMed ID: 11893827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of everolimus-eluting stents in the treatment of drug-eluting stent versus bare-metal stent restenosis.
    Almalla M; Pross V; Marx N; Hoffmann R
    Coron Artery Dis; 2012 Nov; 23(7):492-6. PubMed ID: 22990414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A potential marker of bare metal stent restenosis: monocyte count - to- HDL cholesterol ratio.
    Ucar FM
    BMC Cardiovasc Disord; 2016 Oct; 16(1):186. PubMed ID: 27716070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coronary CT angiography (CCTA) using third-generation dual-source CT for ruling out in-stent restenosis.
    Eckert J; Renczes-Janetzko P; Schmidt M; Magedanz A; Voigtländer T; Schmermund A
    Clin Res Cardiol; 2019 Apr; 108(4):402-410. PubMed ID: 30187179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of stent diameter and length on in-stent restenosis after DES vs BMS implantation in patients needing large coronary stents-A clinical and health-economic evaluation.
    Zbinden R; von Felten S; Wein B; Tueller D; Kurz DJ; Reho I; Galatius S; Alber H; Conen D; Pfisterer M; Kaiser C; Eberli FR
    Cardiovasc Ther; 2017 Feb; 35(1):19-25. PubMed ID: 27662632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Usefulness of the CHA2DS2-VASc Score in Predicting In-Stent Restenosis Among Patients Undergoing Revascularization With Bare-Metal Stents.
    Kurtul A
    Clin Appl Thromb Hemost; 2018 May; 24(4):589-595. PubMed ID: 28675046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-Fasting Hypertriglyceridemia as an Independent Risk Factor for Coronary In-Stent Restenosis after Primary Bare Metal Stent Implantation in Patients with Coronary Artery Disease.
    Yoshimura M; Umemoto S; Kawano R; Hiromoto M; Yamada M; Fujimura T; Tanaka M; Nao T; Miura T; Yano M
    Int Heart J; 2021; 62(5):970-979. PubMed ID: 34588411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Association between 1019C/T polymorphism of Connexin 37 gene and restenosis after coronary stenting].
    Yang Y; Guo SX; Yang ZY; Zhang T; Cao HM; Wang RX
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Aug; 30(4):456-60. PubMed ID: 23926016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rationale and study design of the CardioGene Study: genomics of in-stent restenosis.
    Ganesh SK; Skelding KA; Mehta L; O'Neill K; Joo J; Zheng G; Goldstein J; Simari R; Billings E; Geller NL; Holmes D; O'Neill WW; Nabel EG
    Pharmacogenomics; 2004 Oct; 5(7):952-1004. PubMed ID: 15469413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Relationship between
    Osadnik T; Lekston A; Bujak K; Strzelczyk JK; Poloński L; Gąsior M
    Dis Markers; 2017; 2017():8165219. PubMed ID: 28811677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The association of transforming growth factor beta 1 gene polymorphisms with arthritis: a systematic review and meta-analysis.
    Liu S; Li J; Cui Y
    Clin Exp Med; 2021 May; 21(2):331-340. PubMed ID: 33417083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic variants in CCNB1 associated with differential gene transcription and risk of coronary in-stent restenosis.
    Silvestre-Roig C; Fernández P; Mansego ML; van Tiel CM; Viana R; Anselmi CV; Condorelli G; de Winter RJ; Martín-Fuentes P; Solanas-Barca M; Civeira F; Focaccio A; de Vries CJ; Chaves FJ; Andrés V
    Circ Cardiovasc Genet; 2014 Feb; 7(1):59-70. PubMed ID: 24395923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of insulin resistance on in-stent restenosis in patients undergoing coronary drug-eluting stent implantation after long-term angiographic follow-up.
    Zhao LP; Xu WT; Wang L; Li H; Shao CL; Gu HB; Chan SP; Xu HF; Yang XJ
    Coron Artery Dis; 2015 Jan; 26(1):5-10. PubMed ID: 25211654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The haplotype of the TGFβ1 gene associated with cerebral infarction in Chinese.
    Tao HM; Chen GZ; Cheng GP; Shan XY
    Can J Neurol Sci; 2012 Sep; 39(5):626-31. PubMed ID: 22931704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The characteristics and risk factors of in-stent restenosis in patients with percutaneous coronary intervention: what can we do.
    Wang P; Qiao H; Wang R; Hou R; Guo J
    BMC Cardiovasc Disord; 2020 Dec; 20(1):510. PubMed ID: 33276720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of red blood cell distribution in predicting drug-eluting stent restenosis in patients with stable angina pectoris after coronary stenting.
    Zhao K; Li YJ; Gao S
    Coron Artery Dis; 2015 May; 26(3):220-4. PubMed ID: 25647458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.